Nutraceuticals Corporation Announces Bloomberg Company Profile Updates

Dallas, Texas | October 2026

Nutraceuticals Corporation has received confirmation that Bloomberg has reviewed and updated its corporate information within Bloomberg's business information database.

The review included updates to the company's official website, corporate address, business description, industry classification, and select executive management information. Bloomberg referenced Nutraceuticals Corporation's publicly available leadership and company information as part of the review process.

Nutraceuticals Corporation is a Dallas-based biotechnology company focused on innovative drug delivery technologies and investigational healthcare products. The company's initiatives include next-generation metered-dose inhaler technology and NC-107, an investigational inhaled product being developed for potential applications in anxiety-related conditions.

Maintaining accurate and current corporate information across established business information platforms is part of Nutraceuticals Corporation's ongoing efforts to provide transparency and accessibility to prospective partners, researchers, investors, and other interested stakeholders.